The immune response to respiratory syncytial virus infection: friend or foe? (Q36994294)

17 August 2017

1 reference

title

The immune response to respiratory syncytial virus infection: friend or foe? (English)

1 reference

17 August 2017

Robert C Welliver

1

1 reference

PubMed ID

17985249

17 August 2017

language of work or name

1 reference

1 April 2008

1 reference

Clinical Reviews in Allergy & Immunology

17 August 2017

1 reference

17 August 2017

34

1 reference

17 August 2017

163-173

1 reference

17 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-007-8033-2

17 August 2017

0 references

cites work

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

State of the art: bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-007-8033-2

Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

21 January 2018

1 reference

12 December 2020

Respiratory syncytial virus and pulmonary surfactant

1 reference

12 December 2020

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

12 December 2020

Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin

1 reference

12 December 2020

Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Surfactant protein-A enhances respiratory syncytial virus clearance in vivo

1 reference

12 December 2020

Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants

1 reference

12 December 2020

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

1 reference

12 December 2020

Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma

1 reference

12 December 2020

1 reference

12 December 2020

Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000.

1 reference

12 December 2020

Pulmonary collectins and innate host defense of the lung

1 reference

12 December 2020

Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice

1 reference

12 December 2020

Natural killer cell response to respiratory syncytial virus in the Balb/c mouse model.

1 reference

12 December 2020

Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium

1 reference

12 December 2020

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

12 December 2020

Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity

1 reference

12 December 2020

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

1 reference

12 December 2020

Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus.

1 reference

12 December 2020

Secretory Antibody Response to Respiratory Syncytial Virus Infection

1 reference

12 December 2020

Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha

1 reference

12 December 2020

Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line

1 reference

12 December 2020

Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

1 reference

12 December 2020

Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

1 reference

12 December 2020

Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression

1 reference

12 December 2020

Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis

1 reference

12 December 2020

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology

1 reference

12 December 2020

Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

1 reference

12 December 2020

Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

1 reference

12 December 2020

Sensitization to inhaled antigen by intratracheal instillation of dendritic cells.

1 reference

12 December 2020

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

1 reference

12 December 2020

Nasal cytokine production in viral acute upper respiratory infection of childhood

1 reference

12 December 2020

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

1 reference

12 December 2020

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus

1 reference

12 December 2020

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo

1 reference

12 December 2020

Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity

1 reference

12 December 2020

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

12 December 2020

Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro

1 reference

12 December 2020

HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children

1 reference

12 December 2020

Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology

1 reference

12 December 2020

IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB

1 reference

12 December 2020

Risk factors for severe respiratory syncytial virus infection in elderly persons

1 reference

12 December 2020

Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection

1 reference

12 December 2020

Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs

1 reference

12 December 2020

Airway remodeling in asthma

1 reference

12 December 2020

Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus

1 reference

12 December 2020

Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

1 reference

12 December 2020

Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages

1 reference

12 December 2020

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing

1 reference

12 December 2020

Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays

1 reference

12 December 2020

Direct medical costs of bronchiolitis hospitalizations in the United States.

1 reference

12 December 2020

Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.

1 reference

12 December 2020

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

12 December 2020

Essential roles of NF-kappaB and C/EBP in the regulation of intercellular adhesion molecule-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures

1 reference

12 December 2020

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

1 reference

12 December 2020

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

12 December 2020

The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children

1 reference

12 December 2020

Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates

1 reference

12 December 2020

The interaction of neutrophils with respiratory epithelial cells in viral infection

1 reference

12 December 2020

Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells

1 reference

12 December 2020

Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus

1 reference

12 December 2020

Characterization of dendritic cell populations in the respiratory tract

1 reference

12 December 2020

Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells.

1 reference

12 December 2020

Trends in childhood asthma: prevalence, health care utilization, and mortality

1 reference

12 December 2020

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

1 reference

12 December 2020

Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus

1 reference

12 December 2020

Human chemokines: an update

1 reference

12 December 2020

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

1 reference

12 December 2020

The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses

1 reference

12 December 2020

Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo

1 reference

12 December 2020

Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus.

1 reference

12 December 2020

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

1 reference

12 December 2020

Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus

1 reference

12 December 2020

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

1 reference

12 December 2020

Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus

1 reference

12 December 2020

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

1 reference

12 December 2020

The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection

1 reference

12 December 2020

Zileuton Reduces Respiratory Illness and Lung Inflammation, during Respiratory Syncytial Virus Infection, in Mice

1 reference

12 December 2020

Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

1 reference

12 December 2020

10.1007/S12016-007-8033-2

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17985249